Variability of hemagglutinin-neuraminidase and nucleocapsid protein of vaccine and wild-type mumps virus strains

Infection, Genetics and Evolution

Volumn 8, Issue 5, 2008, Pages 603-613

  Ivancic Jelecki, Jelena ^a   Santak, Maja ^a   Forcic, Dubravko ^a  

^a INSTITUTE OF IMMUNOLOGY   (Croatia)

Author keywords

Antigenic epitopes; Hemagglutinin neuraminidase; Mumps; Mumps vaccine; Nucleocapsid protein; Strain diversity

Indexed keywords

MUMPS VACCINE; NUCLEOCAPSID PROTEIN; VIRUS HEMAGGLUTININ; VIRUS SIALIDASE;

ANTIGEN SPECIFICITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CLADISTICS; CONTROLLED STUDY; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; MUMPS VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; PROTEIN DETERMINATION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; STRAIN DIFFERENCE; VIRUS GENE; VIRUS STRAIN; WILD TYPE;

AMINO ACID SEQUENCE; EVOLUTION, MOLECULAR; GENOTYPE; HN PROTEIN; MOLECULAR SEQUENCE DATA; MUMPS VACCINE; MUMPS VIRUS; NUCLEOCAPSID PROTEINS; PHYLOGENY; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; VARIATION (GENETICS);

MUMPS VIRUS;

EID: 50249131350     PISSN: 15671348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meegid.2008.04.007     Document Type: Article

References (52)

1. Amexis G., Fineschi N., and Chumakov K. Correlation of genetic variability with safety of mumps vaccine Urabe AM9 strain. Virology 287 (2001) 234-241
2. Boriskin Y.S., Booth J.C., and Yamada A. Sequence variation within the carboxyl terminus of the nucleoprotein gene of mumps virus strains. Clin. Diagn. Virol. 2 (1994) 79-85
3. Branovic K., Forcic D., Ivancic J., Strancar A., Barut M., Kosutic-Gulija T., Zgorelec R., and Mazuran R. Application of short monolithic columns for improved detection of viruses. J. Virol. Methods 110 (2003) 163-171
4. Castilla J., García Cenoz M., Barricarte A., Irisarri F., and Nunez-Cordoba J. Mumps outbreak in Navarre region, Spain, 2006-2007. Euro Surveill. 12 (2007) E070215.1
5. Centers for Disease Control and Prevention. Mumps epidemic-United Kingdom, 2004-2005. MMWR Wkly. 55 (2006) 173-175
6. Coronel E.C., Takimoto T., Murti K.G., Varich N., and Portner A. Nucleocapsid incorporation into parainfluenza virus is regulated by a specific interaction with matrix protein. J. Virol. 75 (2001) 1117-1123
7. Crowley B., and Afzal M.A. Mumps virus reinfection-clinical findings and serological vagaries. Commun. Dis. Public Health 5 (2002) 311-313
8. Curran J., Homann H., Buchholz C., Rochat S., Neubert W., and Kolakofsky D. The hypervariable C-terminal tail of the Sendai paramyxovirus nucleocapsid protein is required for template function but not for RNA encapsidation. J. Virol. 67 (1993) 4358-4364
9. Cusi M.G., Fisher S., Sedlmeier R., Valassina M., Valensin P.E., Donati M., and Neubert W.J. Localization of a new neutralizing epitope on the mumps virus hemagglutinin-neuraminidase protein. Virus Res. 74 (2001) 133-137
10. Deeks S., Salvadori M., and Lipskie T. Statement on mumps vaccine. Can. Commun. Dis. Rep. 33 (2007) 1-10
11. Domingo E., and Holland J.J. RNA virus mutations for fitness and survival. Annu. Rev. Microbiol. 51 (1997) 151-178
12. Gut J.P., Lablache C., Behr S., and Kirn A. Symptomatic mumps virus reinfections. J. Med. Virol. 45 (1995) 17-23
13. Heider A., Ignatyev G., Gerike E., and Schreier E. Genotypic characterization of mumps virus isolated in Russia. Res. Virol. 148 (1997) 433-435
14. Heininger U., and Bonhoeffer J. Interstrain antigenic variability of mumps viruses. Clin. Infect. Dis. 46 (2008) 150-151
15. Infectious Disease Surveillance Center. Mumps, Japan, 1993-2002. Infect. Agents Surveill. Rep. 24 (2003) 103-104
16. Ivancic J., Forcic D., Kosutic Gulija T., Zgorelec R., Repalust L., Baricevic M., Mesko-Prejac M., and Mazuran R. Genetic characterization of a mumps virus isolate during passaging in the amniotic cavity of embryonated chicken eggs. Virus Res. 99 (2004) 121-129
17. Ivancic J., Kosutic Gulija T., Forcic D., Baricevic M., Jug R., Mesko-Prejac M., and Mazuran R. Genetic characterization of L-Zagreb mumps vaccine strain. Virus Res. 109 (2005) 95-105
18. Jin L., Brown D.W., Litton P.A., and White J.M. Genetic diversity of mumps virus in oral fluid specimens: application to mumps epidemiological study. J. Infect. Dis. 189 (2004) 1001-1008
19. Jin L., Rima B., Örvell C., Tecle T., Afzal M., Uchida K., Nakayama T., Song J.-W., Kang C., Rota P.A., Xu W., and Featherstone D. Proposal for genetic characterisation of wild-type mumps strains: preliminary standardisation of the nomenclature. Arch. Virol. 150 (2005) 1903-1909
20. Karlin D., Ferron F., Canard B., and Longhi S. Structural disorder and modular organization in Paramyxovirinae N and P. J. Gen. Virol. 84 (2003) 3239-3252
21. Kingsbury D.W. The molecular biology of paramyxoviruses. Med. Microbiol. Immunol. 160 (1974) 73-83
22. Kövamees J., Rydbeck R., Örvell C., and Norrby E. Hemagglutinin-neuraminidase (HN) amino acid alterations in neutralization escape mutants of Kilham mumps virus. Virus Res. 17 (1990) 119-129
23. Kulkarni-Kale U., Ojha J., Manjari S., Deobagkar D.D., Mallya A.D., Dhere R.M., and Kapre S.V. Mapping antigenic diversity and strain specificity of mumps virus: a bioinformatics approach. Virology 359 (2007) 436-446
24. Lim C.S., Chan K.P., Goh K.T., and Chow V.T. Hemagglutinin-neuraminidase and phylogenetic analyses of mumps virus isolates from a vaccinated population in Singapore. J. Med. Virol. 70 (2003) 287-292
25. Marie J.C., Saltel F., Escola J.-M., Jurdic P., Wild T.F., and Horvat B. Cell surface delivery of the measles virus nucleoprotein: a viral strategy to induce immunosuppression. J. Virol. 78 (2004) 11952-11961
26. Montes M., Cilla G., Arttieda J., Vicente D., and Basterretxea M. Mumps outbreak in vaccinated children in Gipuzkoa (Basque Country), Spain. Epidemiol. Infect. 129 (2002) 551-556
27. Mühlemann K. The molecular epidemiology of mumps virus. Infect. Genet. Evol. 4 (2004) 215-219
28. Nöjd J., Tecle T., Samuelsson A., and Örvell C. Mumps virus neutralizing antibodies do not protect against reinfection with a heterologous mumps virus genotype. Vaccine 19 (2001) 1727-1731
29. Örvell C. The reactions of monoclonal antibodies with structural proteins of mumps virus. J. Immunol. 132 (1984) 2622-2629
30. Örvell C., Alsheikhly A.-R., Kalantari M., and Johansson B. Characterization of genotype-specific epitopes of the HN protein of mumps virus. J. Gen. Virol. 78 (1997) 3187-3193
31. Peltola H., Kulkarni P.S., Kapre S.V., Paunio M., Jadhav S.S., and Dhere R.M. Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines. Clin. Infect. Dis. 45 (2007) 459-466
32. Pomeroy L.W., Bjørnstad O.N., and Holmes E.C. The evolutionary and epidemiological dynamics of the Paramyxoviridae. J. Mol. Evol. 66 (2008) 98-106
33. Rubin S., Mauldin J., Chumakov K., Vanderzanden J., Iskow R., and Carbone K. Serological and phylogenetic evidence of monotypic immune responses to different mumps virus strains. Vaccine 24 (2006) 2662-2668
34. Saitou N., and Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4 (1987) 406-425
35. Šantak M., Košutić-Gulija T., Tešović G., Ljubin-Sternak S., Gjenero-Margan I., Betica-Radić L., and Forčić D. Mumps virus strains isolated in Croatia in 1998 and 2005: genotyping and putative antigenic relatedness to vaccine strains. J. Med. Virol. 78 (2006) 638-643
36. Santos C.L., Ishida M.A., Foster P.G., Sallum M.A., Benega M.A., Borges D.B., Corrêa K.O., Constantino C.R., Afzal M.A., and Paiva T.M. Detection of a new mumps virus genotype during parotitis epidemic of 2006-2007 in the State of São Paulo, Brazil. J. Med. Virol. 80 (2008) 323-329
37. Sartorius B., Penttinen P., Nilsson J., Johansen K., Jönsson K., Arneborn M., Löfdahl M., and Giesecke J. An outbreak of mumps in Sweden, February-April 2004. Euro Surveill. 10 (2005) 191-193
38. Sauder C.J., Vandenburgh K.M., Iskow R.C., Malik T., Carbone K.M., and Rubin S.A. Changes in mumps virus neurovirulence phenotype associated with quasispecies heterogeneity. Virology 350 (2006) 48-57
39. Savage E., Ramsay M., White J., Beard S., Lawson H., Hunjan R., and Brown D. Mumps outbreaks across England and Wales in 2004: observational study. BMJ 330 (2005) 1119-1120
40. Schmid D., Pichler A.M., Wallenko H., Holzmann H., and Allerberger F. Mumps outbreak affecting adolescents and young adults in Austria, 2006. Euro Surveill. 11 (2006) E060615.1
41. Schmid D., Pichler A.M., Wallenko H., Holzmann H., Popow-Kraupp T., and Allerberger F. Mumps outbreak affecting adolescents and young adults in Austria, 2006: update. Euro Surveill. 11 (2006) E060706.2
42. Smorodintsev A.A. Mumps live vaccine in the USSR. A summary of recent developments. Prog. Med. Virol. 3 (1961) 273-286
43. Tanabayashi K., Takeuchi K., Hishiyama M., Yamada A., Tsurudome M., Ito Y., and Sugiura A. Nucleotide sequence of the leader and nucleocapsid protein gene of mumps virus and epitope mapping with the in vitro expressed nucleocapsid protein. Virology 177 (1990) 124-130
44. Tecle T., Johansson B., Yun Z., and Örvell C. Antigenic and genetic characterization of the fusion (F) protein of mumps virus strains. Arch. Virol. 145 (2000) 1199-1210
45. Tecle T., Mickiene A., Johansson B., Lindquist L., and Orvell C. Molecular characterisation of two mumps virus genotypes circulating during an epidemic in Lithuania from 1998 to 2000. Arch. Virol. 147 (2002) 243-253
46. Uchida K., Shinohara M., Shimada S., Segawa Y., and Hoshino Y. Characterization of mumps virus isolated in Saitama prefecture, Japan, by sequence analysis of the SH gene. Microbiol. Immunol. 45 (2001) 851-855
47. Wilson R.L., Fuentes S.M., Wang P., Taddeo E.C., Klatt A., Henderson A.J., and He B. Function of small hydrophobic proteins of paramyxovirus. J. Virol. 80 (2006) 1700-1709
48. Wolinsky J.S., Waxham M.N., and Server A.C. Protective effects of glycoprotein-specific monoclonal antibodies on the course of experimental mumps virus meningoencephalitis. J. Virol. 53 (1985) 727-734
49. World Health Organization. Mumps virus vaccines. Wkly. Epidemiol. Rec. 45 (2001) 346-355
50. World Health Organization. Global status of mumps immunization and surveillance. Wkly. Epidemiol. Rec. 48 (2005) 418-424
51. Yates P.J., Afzal M.A., and Minor P.D. Antigenic and genetic variation of the HN protein of mumps virus strains. J. Gen. Virol. 77 (1996) 2491-2499
52. Yoshida N., Fujino M., Miyata A., Nagai T., Kamada M., Sakiyama H., Ihara T., Kumagai T., Okafuji T., Okafuji T., and Nakayama T. Mumps virus reinfection is not a rare event confirmed by reverse transcription loop-mediated isothermal amplification. J. Med. Virol. 80 (2008) 517-523